B4GALNT3 | Beta-1,4-N-acetyl-galactosaminyl transferase 3 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
WNK1 | WNK lysine deficient protein kinase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
ERC1 | ELKS/RAB6-interacting/CAST family member 1 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
DCP1B | Decapping mRNA 1B | | | | | | Expressed in all |
CACNA1C | Calcium channel, voltage-dependent, L type, alpha 1C subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
FKBP4 | FK506 binding protein 4, 59kDa | Enzymes Plasma proteins
| | | | | Expressed in all |
NRIP2 | Nuclear receptor interacting protein 2 | | | | | | Mixed |
FOXM1 | Forkhead box M1 | Cancer-related genes Transcription factors
| | | | | Mixed |
TULP3 | Tubby like protein 3 | | | | | | Expressed in all |
TEAD4 | TEA domain family member 4 | Transcription factors
| | | | | Tissue enhanced |
TSPAN9 | Tetraspanin 9 | Predicted membrane proteins
| | | | | Tissue enhanced |
EFCAB4B | EF-hand calcium binding domain 4B | | | | | | Tissue enhanced |
CCND2 | Cyclin D2 | Cancer-related genes
| | | | | Mixed |
DYRK4 | Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4 | Enzymes
| | | | | Expressed in all |
AKAP3 | A kinase (PRKA) anchor protein 3 | | | | | | Tissue enriched |
NDUFA9 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa | Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
KCNA5 | Potassium voltage-gated channel, shaker-related subfamily, member 5 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
ANO2 | Anoctamin 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
VWF | Von Willebrand factor | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Mixed |
CD9 | CD9 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CD27 | CD27 molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MRPL51 | Mitochondrial ribosomal protein L51 | Mitochondrial proteins
| | | | | Expressed in all |
NCAPD2 | Non-SMC condensin I complex, subunit D2 | Plasma proteins
| | | | | Expressed in all |
GAPDH | Glyceraldehyde-3-phosphate dehydrogenase | Enzymes Plasma proteins
| | | | | Expressed in all |
NOP2 | NOP2 nucleolar protein | Plasma proteins
| | | | | Expressed in all |
CHD4 | Chromodomain helicase DNA binding protein 4 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
ACRBP | Acrosin binding protein | Predicted secreted proteins
| | | | | Tissue enriched |
ZNF384 | Zinc finger protein 384 | Cancer-related genes Transcription factors
| | | | | Expressed in all |
PIANP | PILR alpha associated neural protein | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COPS7A | COP9 signalosome subunit 7A | | | | | | Expressed in all |
MLF2 | Myeloid leukemia factor 2 | | | | | | Expressed in all |
PTMS | Parathymosin | | | | | | Expressed in all |
LAG3 | Lymphocyte-activation gene 3 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD4 | CD4 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
GPR162 | G protein-coupled receptor 162 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CDCA3 | Cell division cycle associated 3 | | | | | | Mixed |
USP5 | Ubiquitin specific peptidase 5 (isopeptidase T) | Enzymes Plasma proteins
| | | | | Expressed in all |
TPI1 | Triosephosphate isomerase 1 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
SPSB2 | SplA/ryanodine receptor domain and SOCS box containing 2 | | | | | | Expressed in all |
LRRC23 | Leucine rich repeat containing 23 | | | | | | Group enriched |
ENO2 | Enolase 2 (gamma, neuronal) | Cancer-related genes Candidate cardiovascular disease genes Enzymes Plasma proteins
| | | | | Expressed in all |
ATN1 | Atrophin 1 | Disease related genes Plasma proteins
| | | | | Expressed in all |
PTPN6 | Protein tyrosine phosphatase, non-receptor type 6 | Enzymes Plasma proteins
| | | | | Expressed in all |
EMG1 | EMG1 N1-specific pseudouridine methyltransferase | | | | | | Expressed in all |
PHB2 | Prohibitin 2 | Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
C1S | Complement component 1, s subcomponent | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
RBP5 | Retinol binding protein 5, cellular | Plasma proteins
| | | | | Tissue enhanced |
PEX5 | Peroxisomal biogenesis factor 5 | Disease related genes
| | | | | Expressed in all |
CD163L1 | CD163 molecule-like 1 | CD markers Predicted membrane proteins
| | | | | Mixed |
CD163 | CD163 molecule | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |